Thomas Christoph
Klinikum Chemnitz(DE)
Publications by Year
Research Areas
Pain Mechanisms and Treatments, Neuropeptides and Animal Physiology, Ion Channels and Receptors, Ion channel regulation and function, Inflammatory mediators and NSAID effects
Most-Cited Works
- → (–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties(2007)389 cited
- → Mechanistic and functional differentiation of tapentadol and tramadol(2012)168 cited
- → Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist(2014)163 cited
- → Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain(2004)150 cited
- → Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo(2006)143 cited
- → Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain(2010)130 cited
- → Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia(2011)125 cited
- → The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro(1999)122 cited
- → Tapentadol hydrochloride: A next-generation, centrally actinganalgesic with two mechanisms of action in a single molecule(2009)119 cited
- → The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol(2014)115 cited